Vodianyk Arkadii, Poniatovskiy Vadym, Shyrobokov Voldymyr
Bogomolets National Medical University, Kyiv, Ukraine.
IJID Reg. 2025 Apr 9;15:100646. doi: 10.1016/j.ijregi.2025.100646. eCollection 2025 Jun.
To determine antimicrobial resistance and biofilm-associated genes among clinical isolates of bloodstream infection pathogens in Ukraine.
A total of 35 clinical strains of and 50 clinical strains of spp. were isolated from patients from Ukrainian tertiary-level children`s hospitals during 2023 with bloodstream infections including central venous catheter-associated infections. Antimicrobial susceptibility testing was conducted following the European Committee on Antimicrobial Susceptibility Testing methodology. Capacity to form biofilms was assessed using a microtiter plate assay. Amplification of the variable resistance genes () and biofilm-associated genes ( was performed by polymerase chain reaction.
|Overall, 96% (n = 46/50) of all Staphylococcus spp. strains expressed icaA, 94% (n = 47/50) of strains expressed fnbpA and 92% (n = 45/50) expressed clfA genes. In total, 32% (n = 16/50) of strains were resistant to methicillin, and all of the strains expressed mecA. All strains expressed , and 97% (n = 34/35) expressed and genes. All of were resistant to third-generation cephalosporins, 74.3% (n = 25/35) of isolates expressed and 80% (n = 28/35) expressed gene, 71.4% (n = 25/35) strains expressed both genes. In total, 80% (n = 28/35) of were resistant to carbapenems, 60.7% (n = 17/28) expressed , 64.3% (n = 18/28) expressed and all 28 strains expressed . A total of 90% (n = 18/20) of were resistant to fluoroquinolones, 88.9% (n = 16/18) expressed and none of the isolates expressed gene.
Very high prevalence of genes associated with biofilm formation was observed in clinical isolates of spp. and . High-level resistance to all antimicrobials was observed in strains.
确定乌克兰血流感染病原体临床分离株中的抗菌药物耐药性及生物膜相关基因。
2023年期间,从乌克兰三级儿童医院患有血流感染(包括中心静脉导管相关感染)的患者中分离出35株金黄色葡萄球菌临床菌株和50株凝固酶阴性葡萄球菌临床菌株。按照欧洲抗菌药物敏感性试验委员会的方法进行抗菌药物敏感性试验。使用微量滴定板法评估形成生物膜的能力。通过聚合酶链反应对可变耐药基因()和生物膜相关基因()进行扩增。
总体而言,所有葡萄球菌属菌株中96%(n = 46/50)表达icaA基因,94%(n = 47/50)表达fnbpA基因,92%(n = 45/50)表达clfA基因。总共32%(n = 16/50)的菌株对甲氧西林耐药,且所有这些菌株均表达mecA基因。所有金黄色葡萄球菌菌株均表达,97%(n = 34/35)表达和基因。所有大肠埃希菌均对第三代头孢菌素耐药,74.3%(n = 25/35)的分离株表达,80%(n = 28/35)表达基因,71.4%(n = 25/35)的菌株同时表达这两个基因。总共80%(n = 28/35)的肺炎克雷伯菌对碳青霉烯类耐药,60.7%(n = 17/28)表达,64.3%(n = 18/28)表达,所有28株均表达。总共90%(n = 18/20)的鲍曼不动杆菌对氟喹诺酮类耐药,88.9%(n = 16/18)表达,且所有分离株均未表达基因。
在葡萄球菌属和其他菌株的临床分离株中观察到与生物膜形成相关基因的高流行率。在肺炎克雷伯菌菌株中观察到对所有抗菌药物的高水平耐药性。